Inventor · disambiguated record
Mark Peter Ridgill
Also filed as: RIDGILL MARK · RIDGILL MARK P · RIDGILL MARK PETER
26 granted patents·11 pending applications·333 citations·filing 1994–2025
95Inventor score
Files withMERCK SHARP & DOHME14STORM THERAPEUTICS LTD7PADLOCK THERAPEUTICS INC3DUERRENBERGER FRANZ2BUHR WILM1
Top patents by PatentIndex Score
37 records- 0192US11725010B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2022·Granted Aug 15, 2023·3 cites·3 claims
- 0292US5576319APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1994·Granted Nov 19, 1996·55 cites·30 claims
- 0391US5700809APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1994·Granted Dec 23, 1997·49 cites·9 claims
- 0490US5432177APyrrolo-pyridine derivativesMERCK SHARPE & DOHME LTD·Filed 1994·Granted Jul 11, 1995·79 cites·6 claims
- 0589US5712285APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1996·Granted Jan 27, 1998·48 cites·7 claims
- 0688US7638629B2Piperidines and related compounds for treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2005·Granted Dec 29, 2009·13 cites·8 claims
- 0787US7144910B2Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2003·Granted Dec 5, 2006·27 cites·10 claims
- 0885US7282513B2Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretaseMERCK SHARP & DOHME·Filed 2006·Granted Oct 16, 2007·7 cites·10 claims
- 0978US12358915B2METTL3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jul 15, 2025·1 cites·18 claims
- 1078US7041689B2Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretaseMERCK SHARP & DOHME·Filed 2003·Granted May 9, 2006·7 cites·16 claims
- 1178US2025122195A1Polyheterocyclic compounds as mettl3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1276US5814644AIndole derivatives as dopamine D4 antagonistsMERCK SHARP & DOHME·Filed 1994·Granted Sep 29, 1998·16 cites·13 claims
- 1371US11026937B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·7 claims
- 1470US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 1570US5622950APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Apr 22, 1997·14 cites·11 claims
- 1666US2025388577A1Mettl3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1764US12195458B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jan 14, 2025·0 cites·21 claims
- 1864US9102688B2Sulfonaminoquinoline hepcidin antagonistsVIFOR INT AG·Filed 2014·Granted Aug 11, 2015·1 cites·16 claims
- 1962US2008070895A1Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretaseCOLLINS IAN J·Filed 2007·Application pending·0 cites
- 2060US2021299115A1Heteroaryl inhibitors of pad4PADLOCK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2156US2024279222A1Processes for the preparation of inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2254US2024101589A1Inhibitors of mettl3STROM THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2353US7041688B2Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's diseaseMERCK SHARP & DOHME LT D·Filed 2003·Granted May 9, 2006·2 cites·8 claims
- 2453US2023391770A1Mettl3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2547US7514459B2Gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Apr 7, 2009·0 cites·12 claims
- 2646US7427621B2Cyclic sulfamides for inhibition of gamma-secretaseMERCK SHARP & DOHME·Filed 2003·Granted Sep 23, 2008·0 cites·8 claims
- 2745US7985758B2Piperidine derivatives for treatment of Alzheimer's diseaseMERCK SHARP & DOHME·Filed 2007·Granted Jul 26, 2011·0 cites·9 claims
- 2843US5830901ATetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridineMERCH SHARP & DOHME LTD·Filed 1995·Granted Nov 3, 1998·7 cites·13 claims
- 2941US7371771B2Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretaseMERCK SHARP & DOHME·Filed 2003·Granted May 13, 2008·0 cites·6 claims
- 3038US5861407ATetrahydropyridine derivatives as dopamine receptor subtype ligandsMERCK SHARP & DOHME·Filed 1997·Granted Jan 19, 1999·1 cites·6 claims
- 3138US2001039286A12-aryl indole derivatives and their use as therapeutic agentsFiled 2001·Application pending·0 cites
- 3238US2012214803A1Novel Sulfonaminoquinoline Hepcidin AntagonistsBUHR WILM·Filed 2012·Application pending·0 cites
- 3337US8389547B2Piperidines and related compounds for the treatment of Alzheimer's diseaseGARCIA YUDITH·Filed 2007·Granted Mar 5, 2013·0 cites·11 claims
- 3436US8222418B2Piperidines and related compounds for the treatment of dementiaHANNAM JOANNE CLARE·Filed 2007·Granted Jul 17, 2012·0 cites·6 claims
- 3529US9963462B2Sepiapterin reductase inhibitorsQUARTET MEDICINE INC·Filed 2016·Granted May 8, 2018·0 cites·27 claims
- 3628US2012202806A1Novel Pyrimidine- And Triazine-Hepcidine AntagonistsDUERRENBERGER FRANZ·Filed 2010·Application pending·0 cites
- 3728US2012214798A1Novel Ethanediamone Hepcidine AntagonistsDUERRENBERGER FRANZ·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →